FIELD: medicine.
SUBSTANCE: invention relates to a method for the treatment of patient suffering from a disease, at which the treatment with cysteamine is prescribed, wherein the disease is a neurological disease or disorder. The method includes the injection to the patient of the effective amount of a composition containing a compound of the formula I or its disulfide, which has a structure selected from the following. In the formulas, R1, R2, R3, R4, R5, R6, R7 and R8 are independently selected from a group consisting of H and C1-5alkyl. The invention also relates to compounds of the first of the specified formulas, where R1 is C1-5alkyl, and R3, R4, R5, R7 and R8 are H, which are used in this method.
EFFECT: proposed method allows for the reduction in cystine levels in patients.
and 
6 cl, 1 dwg, 7 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) WITH USING CYSTEAMINE PRODUCTS | 2008 |
|
RU2498795C2 |
| METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION AND ISCHEMIC DAMAGE | 2012 |
|
RU2638807C2 |
| HALOALLYLAMINE SULFONE DERIVATIVE AS LYSILOXIDASE INHIBITORS AND THEIR USE | 2019 |
|
RU2801092C2 |
| NOVEL PHARMACEUTICAL USE OF THIENO[3,2-D]PYRIMIDIN-4-ONE COMPOUNDS | 2019 |
|
RU2768828C1 |
| METHOD OF TREATING HEPATIC FIBROSES | 2017 |
|
RU2740902C2 |
| THERAPEUTIC AGENT FOR LIVER DISEASES | 2018 |
|
RU2723686C1 |
| TREATMENT OF HEPATIC ADIPOSITIS WITH APPLICATION OF GLUCOCORTICOID AND MINERALOCORTICOID RECEPTOR ANTAGONISTS | 2015 |
|
RU2718921C2 |
| CYANOTHIENOTRIAZOLODIAZEPINES AND METHODS FOR THEIR USE | 2016 |
|
RU2750164C2 |
| METHODS FOR INCREASING HEIGHT OF PEDIATRIC PATIENTS WITH CHOLESTATIC LIVER DISEASE | 2020 |
|
RU2822484C2 |
| INTEGRATED STRESS PATHWAY PRODRUG MODULATORS | 2019 |
|
RU2824500C2 |
